Precision partnerships Sano Genetics actively partners with other organizations (BioMendics, Neuron23) to support patient recruitment and engagement for precision medicine studies, presenting a sales opportunity to offer scalable recruitment and trial optimization solutions for collaborative studies.

MND expansion With Light the Way launching an online genetic testing and counseling platform for motor neurone disease and a Government-backed funding to study genetics related to MND, there is a sales window to offer specialized genetic testing, counseling tools, and patient support services to MND-focused researchers and clinics.

Saliva testing Free saliva test kits program targeting LRRK2-driven Parkinson’s disease indicates an openness to broad screening workflows; potential upsell to enhanced sample collection, logistics, and data integration services for larger research cohorts.

Platform offerings Sano combines genetic testing, recruitment, and long-term engagement on a single platform, suggesting a need for complementary technologies such as data analytics, patient outreach automation, and cloud-based compliance solutions to extend platform capabilities.

Global growth signals Recent funding rounds and executive hires in neuroscience signal ongoing scale-up; opportunity to present enterprise-grade AI-driven study design, trial matching, and partner enablement tools to support their growth trajectory and broaden market reach.